Stuart A. Arbuckle - 24 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Feb 2022
Net transactions value
-$1,651,074
Form type
4
Filing time
28 Feb 2022, 16:19:26 UTC
Previous filing
22 Feb 2022
Next filing
04 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,651,074 -7,246 -10% $227.86 65,066 24 Feb 2022 Direct
holding VRTX Common Stock 140 24 Feb 2022 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.